Home＞Sitemap
Site Top
- News
- Latest News
- Photos
- Categories
- Regulatory
- Business
- Organization
- Academia
- Contents
- Commentary
- Lexicon
- The Column
- Eisai Opts to Codevelop Biogen’s Aducanumab; New MS Copromotion Scheme Sealed(Oct.24)
- Shionogi Ups Earnings Outlook on Milestone Scheme Change(Oct.24)
- AZ’s Olaparib Filed for Breast Cancer in 2nd Submission(Oct.24)
- Mitsubishi Tanabe to Focus on US Approval for VLP Seasonal Flu Vaccine; Aims at 100 Billion Yen Sales for Vaccine Business by FY2030(Oct.24)
- Conditional Early Approval System Gets Underway: MHLW(Oct.23)
